Skip to content

East Asian Gynecologic Oncology Trial Group (EAGOT)

Since 2021

East Asian Gynecologic Oncology Trial Group

To coordinate and conduct international clinical trials in an effort to provide best treatments to East-Asian women with gynecologic cancer

Meetings

View all

Next meeting — to be announced.

  1. 2026 2026 International Symposium of JGOG and EAGOT NIKAI, Shin-Tora Yasuda Building, Tokyo, Japan
  2. 2025 2025 International Symposium of KGOG and EAGOT Asan Medical Center, Seoul, Korea
  3. 2024 The 3rd EAGOT Annual Meeting 2024 Chang Gung International Convention Center, Taoyuan, Taiwan

About EAGOT Since 2021 Mission & Vision

International clinical trials for East Asian women with gynecologic cancer

EAGOT is an international research organization formed by the national clinical trial groups of Japan, Korea, China and Taiwan to coordinate and conduct clinical trials for East Asian women affected by gynecological cancer.

  • Clinical TrialsCoordinate and conduct international academic clinical trials in East Asia
  • Translational ResearchConnect laboratory research with better treatment for patients
  • CollaborationFour national groups working together across borders
  • Taiwanese Gynecologic Oncology Group
  • East Asian Gynecologic Oncology Trial Group
  • AstraZeneca Taiwan
  • Takeda
  • GSK
  • Roche & Foundation Medicine
  • Shinpoong Pharmaceutical
  • MSD Korea